J&J: Potential HIV vaccine falls short in mid-stage study
Study: Patients with severe obesity undergo bariatric surgery too late
31 August 2021Western Balkan nations postpone school openings due to virus
31 August 2021J&J: Potential HIV vaccine falls short in mid-stage study
A potential HIV vaccine being developed by Johnson & Johnson did not provide protection against the virus in a mid-stage study, the drugmaker said Tuesday.
